PMID: 7580637Oct 14, 1995Paper

Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom

BMJ : British Medical Journal

Abstract

To study the effect of intensive therapy of diabetes on the progression to clinical albuminuria in insulin dependent diabetic patients with microalbuminuria. Randomised controlled clinical trial of intensive versus conventional therapy of diabetes for a median of 5 years (range 2-8). Nine hospital based specialist diabetes centres in England and Wales. 70 European insulin dependent diabetic patients aged 17-59 years with microalbuminuria (albumin excretion 30-199 micrograms/min), but without arterial hypertension, recruited from the nine hospital based specialist diabetes centres. Intensive diabetic therapy was allocated to 36 patients (27 men, 9 women) and conventional diabetic therapy to 34 (24 men, 10 women). Development of clinical albuminuria, defined as albumin excretion greater than 200 micrograms/min on at least two consecutive occasions, and rate of change of albumin excretion. Mean glycated haemoglobin concentration, similar at baseline in the two groups (intensive therapy group 10.3% (SEM 1.9%), conventional therapy group 9.8% (1.6%)), fell significantly (by 14%) in the intensive therapy group only. A significant glycaemic separation between the two groups was maintained for up to three years. Progression to clinical...Continue Reading

References

Feb 24, 1989·JAMA : the Journal of the American Medical Association·H P ChaseD O'Brien
Jan 1, 1985·European Journal of Nuclear Medicine·R M FawdryA J Roberts

❮ Previous
Next ❯

Citations

Sep 12, 2000·Current Hypertension Reports·P S Mehler, R W Schrier
May 27, 1999·Health Policy·J B van der Meer, J P Mackenbach
Jun 6, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·George S StergiouAdriani Vazeou
Jan 17, 2003·The New England Journal of Medicine·Daniel J BrotmanSabu Thomas
Sep 13, 2002·The New England Journal of Medicine·Empar LurbeDaniel Batlle
Jun 6, 2003·The New England Journal of Medicine·Bruce A PerkinsAndrzej S Krolewski
Nov 3, 2012·British Medical Bulletin·T Z MinR A Chudleigh
Jul 18, 2001·Current Opinion in Nephrology and Hypertension·H H ParvingS Andersen
Sep 17, 2005·Kidney International·Peter RossingHans-Henrik Parving
Oct 15, 2009·Diabetology & Metabolic Syndrome·Themis ZelmanovitzLuís H Canani
May 30, 2001·Lancet·P RuggenentiG Remuzzi
Nov 13, 2001·Kidney International·H H Parving
Oct 16, 2012·Seminars in Nephrology·Gautam Goel, Bruce A Perkins
Apr 8, 2015·Diabetes & Metabolic Syndrome·Jamal Ahmad
Jun 28, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Sharon G AdlerCynthia C Nast
Feb 17, 2005·Diabetes Research and Clinical Practice·J CederholmUNKNOWN Steering Committee of the Swedish National Diabetes Register
Aug 29, 2006·Arquivos brasileiros de endocrinologia e metabologia·Miriam PecisLuis H Canani
Feb 15, 2014·The Cochrane Database of Systematic Reviews·Birgit FullertonAndrea Siebenhofer
Apr 4, 2003·Diabetes/metabolism Research and Reviews·Giacomo DeferrariValeria Berruti
Jan 30, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·D B DungerR N Dalton
Jun 26, 2003·Journal of Internal Medicine·C E Mogensen
Dec 24, 2004·Diabetes Care·Jorge L GrossThemis Zelmanovitz
May 15, 2002·Journal of Pediatric Endocrinology & Metabolism : JPEM·Mariapina PomilioFrancesco Chiarelli
Sep 22, 2015·The Journal of Clinical Endocrinology and Metabolism·Signe RosenlundSteen Andersen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.